SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-053140
Filing Date
2023-04-28
Accepted
2023-04-28 17:00:47
Documents
12
Period of Report
2023-04-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314003d1_8k.htm   iXBRL 8-K 24383
  Complete submission text file 0001104659-23-053140.txt   200017

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA snpx-20230424.xsd EX-101.SCH 3039
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20230424_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20230424_pre.xml EX-101.PRE 22599
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2314003d1_8k_htm.xml XML 3725
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40458 | Film No.: 23867915
SIC: 2834 Pharmaceutical Preparations